Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1 Gastrointestinal 1 Dermatologic 1

Conditions

Pancreatic Neoplasms 2 Colorectal Neoplasms 2 Tumor Virus Infections 1 Recurrence 1 Neoplasms 1 Neoplasm Metastasis 1 HIV Infections 1 Anus Neoplasms 1 Acquired Immunodeficiency Syndrome 1 AIDS-Related Complex 1

Interventions

Gemcitabine 69 Fluorouracil 44 pembrolizumab 43 Oxaliplatin 42 Capecitabine 40 Bevacizumab 37 Leucovorin 36 Irinotecan 31 Cisplatin 27 Nivolumab 24 Paclitaxel 21 Cetuximab 21 Panitumumab 20 130-nm albumin-bound paclitaxel 20 Sorafenib 18 Albumin-Bound Paclitaxel 18 Drug Therapy 15 Docetaxel 15 Cyclophosphamide 15 Radiotherapy 14 Blood Specimen Collection 14 IFL protocol 12 atezolizumab 11 Exercise 11 Taxes 10 budigalimab 9 Erlotinib Hydrochloride 9 trametinib 8 Folfox protocol 8 Carboplatin 8

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Neoplasms × Interferon alpha-2 × Gastrointestinal × Clear all

NCT00178763 2011-03-03

FR-WB-TT

The University of Texas Health Science Center, Houston

Phase 2 Unknown

Gastrointestinal

Neoplasms, Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡